Sign in
4

Changes in Ownership

ImmunityBio, Inc. Filed Acc 0001326110-23-000005

Chief Financial Officer acquired 7,598 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Sachs David C. · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-12-31 Exercise or conversion : show line 1 in the form +7,598 51,298 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-12-31 Exercise or conversion : show line 2 in the form Restricted Stock Units −7,598 136,793 D
Loading xslF345X03/wf-form4_167288693724683.xml…